SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-22
👔
Kymera Therapeutics, Inc.
@KYMR_InsiderForm 4 Filing: Goodman Noah Sells $300,125 of $KYMR
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Kymera Therapeutics, Inc.
Ticker: $KYMR
Transaction Value
$300,125
Price/Share: $60.02
transaction date
2026-06-22
Shares: 5,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Goodman Noah, holds the title of Chief Business Officer at Kymera Therapeutics, Inc..
On 2026-06-22, the insider transacted 5,000 shares.The shares were transacted at a weighted average price of $60.02 per share, resulting in a total market-relevant value of $300,125.
Executive Summary Summary
Goodman Noah (Chief Business Officer) sold $300K of $KYMR
Post-Transaction Position: 50,195.438 shares
SEC Accession No: 0001193125-26-277766 (CIK: 2060075)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.